BLFS vs. INSP, NVST, PRCT, LIVN, WRBY, NVCR, LMAT, EYE, ENOV, and CNMD
Should you be buying BioLife Solutions stock or one of its competitors? The main competitors of BioLife Solutions include Inspire Medical Systems (INSP), Envista (NVST), PROCEPT BioRobotics (PRCT), LivaNova (LIVN), Warby Parker (WRBY), NovoCure (NVCR), LeMaitre Vascular (LMAT), National Vision (EYE), Enovis (ENOV), and CONMED (CNMD). These companies are all part of the "medical equipment" industry.
BioLife Solutions vs. Its Competitors
Inspire Medical Systems (NYSE:INSP) and BioLife Solutions (NASDAQ:BLFS) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their valuation, risk, earnings, profitability, analyst recommendations, institutional ownership, media sentiment and dividends.
Inspire Medical Systems has a net margin of 7.92% compared to BioLife Solutions' net margin of -11.81%. Inspire Medical Systems' return on equity of 10.00% beat BioLife Solutions' return on equity.
Inspire Medical Systems has higher revenue and earnings than BioLife Solutions. BioLife Solutions is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks.
Inspire Medical Systems has a beta of 1.25, meaning that its stock price is 25% more volatile than the S&P 500. Comparatively, BioLife Solutions has a beta of 1.79, meaning that its stock price is 79% more volatile than the S&P 500.
94.9% of Inspire Medical Systems shares are owned by institutional investors. Comparatively, 93.2% of BioLife Solutions shares are owned by institutional investors. 2.3% of Inspire Medical Systems shares are owned by insiders. Comparatively, 2.2% of BioLife Solutions shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Inspire Medical Systems currently has a consensus target price of $211.91, suggesting a potential upside of 62.23%. BioLife Solutions has a consensus target price of $31.17, suggesting a potential upside of 37.00%. Given Inspire Medical Systems' higher probable upside, equities research analysts clearly believe Inspire Medical Systems is more favorable than BioLife Solutions.
In the previous week, Inspire Medical Systems had 2 more articles in the media than BioLife Solutions. MarketBeat recorded 3 mentions for Inspire Medical Systems and 1 mentions for BioLife Solutions. BioLife Solutions' average media sentiment score of 1.79 beat Inspire Medical Systems' score of 1.71 indicating that BioLife Solutions is being referred to more favorably in the news media.
Summary
Inspire Medical Systems beats BioLife Solutions on 12 of the 16 factors compared between the two stocks.
Get BioLife Solutions News Delivered to You Automatically
Sign up to receive the latest news and ratings for BLFS and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding BLFS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
BioLife Solutions Competitors List
Related Companies and Tools
This page (NASDAQ:BLFS) was last updated on 7/2/2025 by MarketBeat.com Staff
Free BLFS Stock Alerts